糖尿病母亲的婴儿口服养挑战
1Pediatrics, Division of Neonatology, University of Texas Health San Antonio, San Antonio, TX, United States.
Frontiers in pediatrics
|September 24, 2024
概括
糖尿病母亲 (IDM) 的婴儿经常因行为和生理挑战而面临口服养延迟. 了解这些因素对于改善婴儿护理和减少住院时间至关重要.
科学领域:
- 新生儿护理 新生儿护理
- 发育儿科 发育儿科
- 孕产妇和胎儿的医学
背景情况:
- 怀孕期间的糖尿病与日产周围风险的增加有关.
- 糖尿病母亲 (IDM) 的婴儿可能会出现诸如巨眼症和低血糖症等并发症.
- IDM经常出现食困难,影响住院时间,需要补充食.
研究的目的:
- 审查可能导致IDM口服养延迟的因素.
- 探索婴儿行为和吞机制在IDM中的差异.
- 了解这个人群中食困难的病因学.
主要方法:
- 对现有文献进行描述性审查.
- 分析婴儿行为,状态调节和自主控制.
- 检查吸和吞的机制.
主要成果:
- 一些IDM表现出维持警报状态的困难,并表现出自主调节和运动控制的下降.
- 研究表明,在IDM中,吸压力降低,吸爆发减少,食道关节功能减缓.
- 这些养延迟的根本原因尚未完全理解.
结论:
- 妊娠期糖尿病的患病率不断上升,需要对IDM养行为进行进一步研究.
- 研究IDM的特征和发展轨迹是必不可少的.
- 了解这些因素可以为临床干预和IDM的支持提供信息.
相关概念视频
Pathophysiology of Diabetes
900
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
900
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Diabetes Mellitus: Overview and Type I Subtype
2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications
516
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
516
Enteral Nutrition II: Nasointestinal and Gastrostomy Feeding
85
Enteral nutrition encompasses various methods of delivering nutrition directly to the gastrointestinal (GI) tract, bypassing traditional oral intake. It is particularly beneficial for patients who cannot eat by mouth but have a functioning digestive system. Key methods include nasointestinal feeding, gastrostomy, and jejunostomy, each suited to different clinical scenarios based on the patient's needs and condition.
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
Nasointestinal Feeding
Nasointestinal feeding involves placing a tube...
85
Insulin: Dosing Regimen and Adverse Effects
156
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
156


